scPharmaceuticals Inc.
DelistedCIK 1604950fmd_1EP10VY6M9FKM939Y7TA5X4R9EManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2025, 35 periods
Latest annual · FY2024
Millions- Total revenues
- 36
- Gross profit
- 25
- Operating income
- (65)
- Net income
- (85)
- Free cash flow
- (71)
Latest quarter · Q2 FY2025
Millions- Total revenues
- 16
- Gross profit
- 11
- Operating income
- (14)
- Net income
- (18)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
scPharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $36.3 million | $13.6 million | +167.3% | 10-K 2025-03-19 · proof |
| Gross profit | $25 million | $9.8 million | +155.3% | 10-K 2025-03-19 · proof |
| Operating income | -$64.8 million | -$55.4 million | 10-K 2025-03-19 · proof | |
| Net income | -$85.1 million | -$54.8 million | 10-K 2025-03-19 · proof | |
| Cash from operating activities | -$70.5 million | -$59.2 million | 10-K 2025-03-19 · proof | |
| Free cash flow | -$70.6 million | -$59.3 million | 10-K 2025-03-19 · proof | |
| Total assets | $107.5 million | $94.5 million | +13.8% | 10-K 2025-03-19 · proof |
| Total liabilities | $94.2 million | $57.3 million | +64.5% | 10-K 2025-03-19 · proof |
| Cash and cash equivalents | $75.7 million | $46.8 million | +61.6% | 10-K 2025-03-19 · proof |
- What was scPharmaceuticals Inc.'s revenue in fiscal 2024?
- scPharmaceuticals Inc. reported revenue of $36.3 million for fiscal 2024 (the year ended Dec 31, 2024), against $13.6 million the year before (+167.3%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was scPharmaceuticals Inc.'s gross profit in fiscal 2024?
- scPharmaceuticals Inc. reported gross profit of $25 million for fiscal 2024 (the year ended Dec 31, 2024), against $9.8 million the year before (+155.3%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was scPharmaceuticals Inc.'s operating income in fiscal 2024?
- scPharmaceuticals Inc. reported operating income of -$64.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$55.4 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was scPharmaceuticals Inc.'s net income in fiscal 2024?
- scPharmaceuticals Inc. reported net income of -$85.1 million for fiscal 2024 (the year ended Dec 31, 2024), against -$54.8 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was scPharmaceuticals Inc.'s cash from operating activities in fiscal 2024?
- scPharmaceuticals Inc. reported cash from operating activities of -$70.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$59.2 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was scPharmaceuticals Inc.'s free cash flow in fiscal 2024?
- scPharmaceuticals Inc. reported free cash flow of -$70.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$59.3 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are scPharmaceuticals Inc.'s total assets?
- As of Dec 31, 2024, scPharmaceuticals Inc. reported total assets of $107.5 million, against $94.5 million a year earlier (+13.8%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are scPharmaceuticals Inc.'s total liabilities?
- As of Dec 31, 2024, scPharmaceuticals Inc. reported total liabilities of $94.2 million, against $57.3 million a year earlier (+64.5%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are scPharmaceuticals Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, scPharmaceuticals Inc. reported cash and cash equivalents of $75.7 million, against $46.8 million a year earlier (+61.6%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1604950&period_type=annual&limit=5"Information only, not investment advice.